Equillium Statistics
Total Valuation
Equillium has a market cap or net worth of $61.88 million. The enterprise value is $20.60 million.
| Market Cap | 61.88M |
| Enterprise Value | 20.60M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Equillium has 35.25 million shares outstanding. The number of shares has increased by 2.96% in one year.
| Shares Outstanding | 35.25M |
| Shares Change (YoY) | +2.96% |
| Shares Change (QoQ) | +0.80% |
| Owned by Insiders (%) | 36.42% |
| Owned by Institutions (%) | 21.77% |
| Float | 17.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 3.44 |
| PS Ratio | 1.68 |
| Forward PS | 1.48 |
| PB Ratio | 2.69 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.57 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.04.
| Current Ratio | 1.79 |
| Quick Ratio | 1.62 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -24.98 |
Financial Efficiency
Return on equity (ROE) is -51.80% and return on invested capital (ROIC) is -62.07%.
| Return on Equity (ROE) | -51.80% |
| Return on Assets (ROA) | -22.60% |
| Return on Capital (ROIC) | -62.07% |
| Revenue Per Employee | $820,091 |
| Profits Per Employee | -$303,068 |
| Employee Count | 44 |
| Asset Turnover | 0.61 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Equillium has paid $580,000 in taxes.
| Income Tax | 580,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +180.73% in the last 52 weeks. The beta is 1.67, so Equillium's price volatility has been higher than the market average.
| Beta (1Y) | 1.67 |
| 52-Week Price Change | +180.73% |
| 50-Day Moving Average | 2.27 |
| 200-Day Moving Average | 1.12 |
| Relative Strength Index (RSI) | 40.03 |
| Average Volume (30 Days) | 371,264 |
Short Selling Information
The latest short interest is 394,469, so 1.12% of the outstanding shares have been sold short.
| Short Interest | 394,469 |
| Short Previous Month | 408,902 |
| Short % of Shares Out | 1.12% |
| Short % of Float | 2.22% |
| Short Ratio (days to cover) | 1.53 |
Income Statement
In the last 12 months, Equillium had revenue of $36.08 million and -$13.34 million in losses. Loss per share was -$0.38.
| Revenue | 36.08M |
| Gross Profit | 36.08M |
| Operating Income | -14.52M |
| Pretax Income | -12.76M |
| Net Income | -13.34M |
| EBITDA | -12.14M |
| EBIT | -12.26M |
| Loss Per Share | -$0.38 |
Balance Sheet
The company has $40.87 million in cash and $824,000 in debt, giving a net cash position of $40.04 million or $1.14 per share.
| Cash & Cash Equivalents | 40.87M |
| Total Debt | 824,000 |
| Net Cash | 40.04M |
| Net Cash Per Share | $1.14 |
| Equity / Book Value | 22.57M |
| Book Value Per Share | 0.64 |
| Working Capital | 21.78M |
Cash Flow
In the last 12 months, operating cash flow was -$21.78 million and capital expenditures -$50,000, giving a free cash flow of -$21.83 million.
| Operating Cash Flow | -21.78M |
| Capital Expenditures | -50,000 |
| Free Cash Flow | -21.83M |
| FCF Per Share | -$0.63 |
Margins
Gross margin is 100.00%, with operating and profit margins of -40.24% and -36.96%.
| Gross Margin | 100.00% |
| Operating Margin | -40.24% |
| Pretax Margin | -35.35% |
| Profit Margin | -36.96% |
| EBITDA Margin | -33.64% |
| EBIT Margin | -33.99% |
| FCF Margin | -60.51% |
Dividends & Yields
Equillium does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.96% |
| Shareholder Yield | -2.96% |
| Earnings Yield | -21.99% |
| FCF Yield | -36.01% |
Analyst Forecast
The average price target for Equillium is $3.90, which is 122.22% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.90 |
| Price Target Difference | 122.22% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Equillium has an Altman Z-Score of -3.41 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.41 |
| Piotroski F-Score | 2 |